7FV4 | pdb_00007fv4

PanDDA analysis group deposition -- PHIP in complex with Z44602341


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.15 Å
  • R-Value Free: 
    0.192 (Depositor), 0.240 (DCC) 
  • R-Value Work: 
    0.177 (Depositor), 0.220 (DCC) 
  • R-Value Observed: 
    0.178 (Depositor) 

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history


Literature

Structure-activity relationships can be directly extracted from high-throughput crystallographic evaluation of fragment elaborations in crude reaction mixtures.

Grosjean, H.Fieseler, K.K.Sanchez-Garcia, R.Thompson, W.Deane, C.M.von Delft, F.Biggin, P.C.

(2025) Chem Sci 

  • DOI: https://doi.org/10.1039/d5sc04919a
  • Primary Citation of Related Structures:  
    7FUS, 7FUT, 7FUU, 7FUV, 7FUW, 7FUX, 7FUY, 7FUZ, 7FV0, 7FV1, 7FV2, 7FV3, 7FV4, 7FV5, 7FV6, 7FV7, 7FV8, 7FV9, 7FVA, 7FVB, 7FVC, 7FVD, 7FVE, 7FVF, 7FVG, 7FVH, 7FVI, 7FVJ, 7FVK, 7FVL, 7FVM, 7FVN, 7FVO, 7FVP, 7FVQ, 7FVR

  • PubMed Abstract: 

    Fragment-based drug design offers multiple routes to advance from fragments. One approach is to build structure-activity relationships (SAR) from analogue series in direct-to-biology workflows. Analogues can be prepared by automated chemistry and tested as crude reaction mixtures (CRMs) without purification, but assay noise often leads to hit resynthesis, potentially discarding false negatives and reducing SAR dataset size. High-throughput (HT) X-ray crystallography has the potential to address these issues by resolving hits directly from 100s-1000s of CRMs. However, no systematic analytics exist for extracting SAR models from HT crystallographic evaluation of CRMs. Here, we demonstrate that crystallographic SAR (xSAR) can be extracted from CRMs evaluated via HT X-ray crystallography. We developed a simple rule-based ligand scoring scheme that identifies conserved chemical features associated with crystallographic binding and non-binding. Applied to a crystallographic dataset of 957 fragment elaborations in CRMs targeting PHIP(2), a therapeutically relevant bromodomain, our xSAR model demonstrated effectiveness in two proof-of-concept experiments. First, it recovered 26 missed binders in the initial dataset (false negatives), doubling the hit rate and denoising the dataset. Second, it enabled a prospective virtual screen that identified novel hits with informative chemistries and measurable binding affinities. This work establishes a proof-of-concept that xSAR models can be directly extracted from large-scale crystallographic readouts of CRMs, offering a valuable methodology to build SAR models and accelerate design-make-test iterations without requiring CRM hit resynthesis and confirmation. This invites future work to utilise advanced analytics and modelling techniques to further strengthen purification-agnostic workflows.


  • Organizational Affiliation
    • Structural Bioinformatics and Computational Biochemistry, Department of Biochemistry, University of Oxford South Parks Road Oxford OX1 3QU UK.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
PH-interacting protein149Homo sapiensMutation(s): 0 
Gene Names: PHIPDCAF14WDR11
UniProt & NIH Common Fund Data Resources
Find proteins for Q8WWQ0 (Homo sapiens)
Explore Q8WWQ0 
Go to UniProtKB:  Q8WWQ0
PHAROS:  Q8WWQ0
GTEx:  ENSG00000146247 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ8WWQ0
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
ZKQ (Subject of Investigation/LOI)
Query on ZKQ

Download Ideal Coordinates CCD File 
B [auth A]N-(2-fluorophenyl)-4-(furan-2-carbonyl)piperazine-1-carboxamide
C16 H16 F N3 O3
DRSQTYLODSUBKE-UHFFFAOYSA-N
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.15 Å
  • R-Value Free:  0.192 (Depositor), 0.240 (DCC) 
  • R-Value Work:  0.177 (Depositor), 0.220 (DCC) 
  • R-Value Observed: 0.178 (Depositor) 
Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 81.883α = 90
b = 27.236β = 99.95
c = 56.313γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
Aimlessdata scaling
PDB_EXTRACTdata extraction
XDSdata reduction
REFMACphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Wellcome TrustUnited Kingdom--

Revision History  (Full details and data files)

  • Version 1.0: 2023-03-29
    Type: Initial release
  • Version 1.1: 2024-05-22
    Changes: Data collection
  • Version 1.2: 2026-01-21
    Changes: Database references, Structure summary
  • Version 1.3: 2026-01-28
    Changes: Database references